162 related articles for article (PubMed ID: 31432409)
1. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.
Ziganshin RH; Kovalchuk SI; Azarkin IV
Methods Mol Biol; 2019; 2044():111-118. PubMed ID: 31432409
[TBL] [Abstract][Full Text] [Related]
2. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
3. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
4. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
Anjo SI; Santa C; Manadas B
Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
[TBL] [Abstract][Full Text] [Related]
5. Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
Hölttä M; Zetterberg H; Mirgorodskaya E; Mattsson N; Blennow K; Gobom J
PLoS One; 2012; 7(8):e42555. PubMed ID: 22880031
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using
Birke R; Krause E; Schümann M; Blasig IE; Haseloff RF
Methods Mol Biol; 2019; 2044():119-128. PubMed ID: 31432410
[TBL] [Abstract][Full Text] [Related]
7. Expanding the cerebrospinal fluid endopeptidome.
Hansson KT; Skillbäck T; Pernevik E; Kern S; Portelius E; Höglund K; Brinkmalm G; Holmén-Larsson J; Blennow K; Zetterberg H; Gobom J
Proteomics; 2017 Mar; 17(5):. PubMed ID: 28044435
[TBL] [Abstract][Full Text] [Related]
8. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
9. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
Hölttä M; Minthon L; Hansson O; Holmén-Larsson J; Pike I; Ward M; Kuhn K; Rüetschi U; Zetterberg H; Blennow K; Gobom J
J Proteome Res; 2015 Feb; 14(2):654-63. PubMed ID: 25490617
[TBL] [Abstract][Full Text] [Related]
10. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
11. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
12. Untargeted Metabolomics Relative Quantification by SWATH Mass Spectrometry Applied to Cerebrospinal Fluid.
Mendes VM; Coelho M; Manadas B
Methods Mol Biol; 2019; 2044():321-336. PubMed ID: 31432422
[TBL] [Abstract][Full Text] [Related]
13. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome.
Bora A; Anderson C; Bachani M; Nath A; Cotter RJ
J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003
[TBL] [Abstract][Full Text] [Related]
14. The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.
Ziganshin RH; Ivanova OM; Lomakin YA; Belogurov AA; Kovalchuk SI; Azarkin IV; Arapidi GP; Anikanov NA; Shender VO; Piradov MA; Suponeva NA; Vorobyeva AA; Gabibov AG; Ivanov VT; Govorun VM
Mol Cell Proteomics; 2016 Jul; 15(7):2366-78. PubMed ID: 27143409
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
16. Sample Fractionation Techniques for CSF Peptide Spectral Library Generation.
Pacharra S; Marcus K; May C
Methods Mol Biol; 2019; 2044():69-77. PubMed ID: 31432407
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
[TBL] [Abstract][Full Text] [Related]
18. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
19. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
20. A rapid method for preparation of the cerebrospinal fluid proteome.
Larssen E; Brede C; Hjelle AB; Øysaed KB; Tjensvoll AB; Omdal R; Ruoff P
Proteomics; 2015 Jan; 15(1):10-5. PubMed ID: 25307358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
